Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Leavitt

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosisR Y Leavitt, A S Fauci, D A Bloch, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitisL H Calabrese, B A Michel, D A Bloch, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritisG G Hunder, D A Bloch, B A Michel, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of vasculitis. SummaryJ F Fries, G G Hunder, D A Bloch, et al.
Arthritis and Rheumatism|August 11, 1990
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosaR W Lightfoot, B A Michel, D A Bloch, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of vasculitis. IntroductionG G Hunder, W P Arend, D A Bloch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell TransplantationPer Ljungman, Michael Schmitt, Francisco M Marty, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.
AIDS Research and Human Retroviruses|December 26, 2008
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsClayton D Harro, Michael N Robertson, Michelle A Lally, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|April 1, 2000
Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell counts between 50 and 250/mm3D S Lewi, J M Suleiman, D E Uip, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosisR Y Leavitt, A S Fauci, D A Bloch, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitisL H Calabrese, B A Michel, D A Bloch, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritisG G Hunder, D A Bloch, B A Michel, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of vasculitis. SummaryJ F Fries, G G Hunder, D A Bloch, et al.
Arthritis and Rheumatism|August 11, 1990
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosaR W Lightfoot, B A Michel, D A Bloch, et al.
Arthritis and Rheumatism|August 1, 1990
The American College of Rheumatology 1990 criteria for the classification of vasculitis. IntroductionG G Hunder, W P Arend, D A Bloch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell TransplantationPer Ljungman, Michael Schmitt, Francisco M Marty, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.
AIDS Research and Human Retroviruses|December 26, 2008
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsClayton D Harro, Michael N Robertson, Michelle A Lally, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|April 1, 2000
Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell counts between 50 and 250/mm3D S Lewi, J M Suleiman, D E Uip, et al.
Pageof 6